RESUMO
INTRODUCTION: Vaccine surveillance for children in England focuses on coverage at ages 1, 2, and 5 years. Previous studies exploring vaccine timeliness have used different arbitrary categories to define whether vaccines were received 'late' or 'on time'. This paper aims to provide more detailed and holistic information on timing and patterns of vaccine uptake across the childhood immunisation schedule in England. METHODS: We included all children born in England between 2006 and 2014 and registered in the Clinical Practice Research Datalink (CPRD) Aurum, a primary care electronic health record. We described vaccine uptake for representative antigens (pertussis, pneumococcus, measles) by age in days and stratified by ethnicity, region and birth cohort. Alluvial diagrams were used to illustrate common journeys through the vaccination schedule, and we applied survival analysis using accelerated failure time models (AFT) to predict age of vaccine receipt based on timing of previous doses. RESULTS: 573,015 children were followed up until their fifth birthday, when they had 90.16 % coverage for two doses of measles, mumps, rubella (MMR) vaccine and 88.78% coverage for four doses of diphtheria, tetanus, pertussis (DTP) vaccine. Overall, the later the age at which a vaccine was due, the more delay in vaccination. Children of Black Ethnicity or from London showed deviating uptake patterns. If a child received their third DTP dose more than a year later than recommended, they would receive the next dose 2.7 times later than a child who was vaccinated on time. A smaller delay was found for children who did not receive first MMR dose on time. DISCUSSION: We showed that the risk of vaccination delay increased with the age of the child and significant delay of previous doses. Primary care data can help to promptly identify children at higher risk of delayed vaccination.
Assuntos
Sarampo , Caxumba , Coqueluche , Criança , Humanos , Lactente , Vacina contra Sarampo-Caxumba-Rubéola , Estudos de Coortes , Vacinação , Esquemas de Imunização , Sarampo/prevenção & controle , Caxumba/prevenção & controle , Vacina contra Difteria, Tétano e CoquelucheRESUMO
PURPOSE: To analyze the presentation of mumps and mumps orchitis using the National Health Insurance Service Database (NHISD). MATERIALS AND METHODS: Using information from the NHISD representing all cases of mumps in Korea, data regarding mumps orchitis were analyzed. The International Classification of Diseases, Tenth Revision, and Clinical Modification codes were used for diagnosis. The incidence estimates of the number of mumps cases were analyzed using the Statistical Analysis System (SAS) software. RESULTS: Based on the NHISD, 199,186 people were diagnosed with mumps, and males accounted for 62.3% cases. Teen males accounted for 69,870 cases, the largest number of patients diagnosed with mumps. The annual incidence of mumps increased every year (poisson regression, hazard ratio [HR] 1.026, 95% confidence interval [CI] 1.024-1.027; p<0.025). The risk of mumps was lower in females than that in males (poisson regression, HR 0.594, 95% CI 0.589-0.599; p<0.001). Of the 199,186 patients diagnosed with mumps, 3,872 patients (1.9%) had related complications. Among the mumps complications, the most diagnosed complication was mumps orchitis, which was seen in 41.8% of the males. Mumps orchitis cases accounted for less than 1.5% of the patients with mumps in minors under the age of 20 years and was somewhat higher in 2009 and 2013-2015. CONCLUSIONS: Among the complications related to mumps, meningitis was most common in females, while orchitis was dominant in males. Mumps orchitis also shows periodic outbreaks but is particularly prevalent in adults, which suggests the potential need for additional vaccination against mumps.
Assuntos
Caxumba , Orquite , Masculino , Adulto , Adolescente , Feminino , Humanos , Adulto Jovem , Caxumba/complicações , Caxumba/epidemiologia , Caxumba/diagnóstico , Orquite/epidemiologia , Orquite/etiologia , Orquite/diagnóstico , Incidência , Programas Nacionais de Saúde , República da Coreia/epidemiologiaRESUMO
PURPOSE: To describe a case of outer retinitis with frosted branch angiitis associated with mumps infection treated with hyperbaric oxygen (HBO) therapy. METHODS: Observational case report. CASE REPORT: A four-year-old boy with bilateral blindness was diagnosed with necrotizing outer retinitis with frosted branch angiitis associated with serologically confirmed mumps virus infection. He was treated with HBO therapy. Visual acuity subsequently improved to 20/40 in the right eye and to 20/320 in the left eye. Sequential follow-up optical coherence tomography examinations showed progressive recovery of the outer retinal layers in the right eye. CONCLUSION: HBO therapy appears to be a feasible and safe treatment that might improve the anatomical and functional outcome in patients with mumps retinitis.
Assuntos
Oxigenoterapia Hiperbárica , Caxumba , Vasculite Retiniana , Retinite , Vasculite , Pré-Escolar , Humanos , Oxigenoterapia Hiperbárica/efeitos adversos , Masculino , Caxumba/complicações , Vasculite Retiniana/diagnóstico , Retinite/diagnóstico , Retinite/etiologia , Retinite/terapia , Tomografia de Coerência Óptica , Vasculite/diagnósticoRESUMO
INTRODUCTION: Children may receive measles-mumps-rubella (MMR) and varicella (VAR) vaccines separately or as measles-mumps-rubella-varicella (MMRV). We examined whether pediatric herpes zoster (HZ) incidence varied by pattern of varicella vaccine administration. METHODS: In six integrated health systems, we examined HZ incidence among children turning 12 months old during 2003-2008. All received varicella and MMR vaccines on recommended schedules. Cases were identified through 2014 using ICD-9 codes. Incidence was examined by number of varicella vaccine doses and same-day MMR. RESULTS: Among 199,797 children, overall HZ incidence was 18.6/100,000 person-years in the first-dose MMR + VAR group, 17.9/100,000 person-years in the MMRV group, and 7.5/100,000 person-years in the VAR-alone group. HZ incidence was lower following the second dose than before the second dose in all first-dose groups. CONCLUSIONS: HZ incidence was not meaningfully different between the MMRV and MMR + VAR first-dose groups. Overall and within first-dose groups, HZ incidence was lower among children receiving two varicella vaccine doses.
Assuntos
Varicela , Herpes Zoster , Sarampo , Caxumba , Anticorpos Antivirais , Varicela/epidemiologia , Varicela/prevenção & controle , Vacina contra Varicela , Herpes Zoster/epidemiologia , Herpes Zoster/prevenção & controle , Humanos , Incidência , Lactente , Vacina contra Sarampo-Caxumba-Rubéola , Caxumba/epidemiologia , Caxumba/prevenção & controle , Vacinas CombinadasRESUMO
BACKGROUND: Influenza, measles, and mumps are common viral infectious diseases in Mongolia. The traditional Mongolian medicine (TMM) classified them as warm disease, and still plays a major role in the diagnoses and treatments. METHODS: To interpret the connotation of the complex theoretical system in TMM with scientific technique, in this study, a high throughput mass spectrometry was used to identify potential protein markers of TMM symptom types. Fifty venous blood samples were drawn from influenza, measles and mumps patients. Differential proteins between samples of patients diagnosed as immature and mature heat in TMM were detected by mass spectrometry. RESULTS: After proteomics analysis, 1500 proteins and 7619 polypeptides were identified and 1323 in total showed differential expression between those 2 symptom types; then enrichment analysis of the differentially expressed proteins revealed the significant biological functions related to the differentially expressed proteins, including cardiomyopathy, several bacterial and parasitic infections, bacterial invasion of epithelial cells, insulin signaling pathway, and regulation of actin cytoskeleton. The network analysis showed that FBP2 and Talin-1 were critical points and might determine the evolution directions of TMM warm disease symptom. CONCLUSIONS: This study suggests that the identified core differential proteins may be regarded as potential biomarkers, and benefit to evaluate the evolutionary tendency of TMM warm disease symptoms.
Assuntos
Frutose-Bifosfatase/sangue , Influenza Humana/diagnóstico , Sarampo/diagnóstico , Medicina Tradicional da Mongólia/métodos , Caxumba/diagnóstico , Talina/sangue , Adolescente , Adulto , Idoso , Biomarcadores/sangue , Ensaios de Triagem em Larga Escala , Humanos , Espectrometria de Massas , Pessoa de Meia-Idade , Proteômica , Adulto JovemRESUMO
Patients with inflammatory bowel disease (IBD) do not receive routine preventative care at the same rate as general medical patients. This patient population is at increased risk of vaccine preventable illness such as influenza and pneumococcal pneumonia. This review will discuss health maintenance needs and preventative care issues in patients with IBD.
Assuntos
Neoplasias Colorretais/diagnóstico , Imunossupressores/efeitos adversos , Doenças Inflamatórias Intestinais/terapia , Medicina Preventiva/métodos , Vacinação/métodos , Conservadores da Densidade Óssea/uso terapêutico , Varicela/etiologia , Varicela/imunologia , Varicela/prevenção & controle , Vacina contra Varicela/uso terapêutico , Depressão/diagnóstico , Depressão/terapia , Gerenciamento Clínico , Detecção Precoce de Câncer/métodos , Hepatite Viral Humana/etiologia , Hepatite Viral Humana/imunologia , Hepatite Viral Humana/prevenção & controle , Herpes Zoster/etiologia , Herpes Zoster/imunologia , Herpes Zoster/prevenção & controle , Vacina contra Herpes Zoster/uso terapêutico , Humanos , Hospedeiro Imunocomprometido , Vacinas contra Influenza/uso terapêutico , Influenza Humana/etiologia , Influenza Humana/imunologia , Influenza Humana/prevenção & controle , Sarampo/etiologia , Sarampo/imunologia , Sarampo/prevenção & controle , Vacina contra Sarampo-Caxumba-Rubéola/uso terapêutico , Meningite Meningocócica/etiologia , Meningite Meningocócica/imunologia , Meningite Meningocócica/prevenção & controle , Vacinas Meningocócicas/uso terapêutico , Caxumba/etiologia , Caxumba/imunologia , Caxumba/prevenção & controle , Osteoporose/diagnóstico por imagem , Osteoporose/tratamento farmacológico , Infecções por Papillomavirus/etiologia , Infecções por Papillomavirus/imunologia , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/uso terapêutico , Vacinas Pneumocócicas/uso terapêutico , Pneumonia Pneumocócica/etiologia , Pneumonia Pneumocócica/imunologia , Pneumonia Pneumocócica/prevenção & controle , Rubéola (Sarampo Alemão)/etiologia , Rubéola (Sarampo Alemão)/imunologia , Rubéola (Sarampo Alemão)/prevenção & controle , Abandono do Hábito de Fumar , Vacinas contra Hepatite Viral/uso terapêutico , Vitamina D/uso terapêutico , Deficiência de Vitamina D/diagnósticoRESUMO
BACKGROUND: Mumps is an infectious disease caused by the mumps virus. Chinese physicians generally believe that Chinese medicinal herbs are effective in alleviating symptoms and reducing the duration of mumps. Herbalists tend to develop a treatment plan according to the individual's symptoms. OBJECTIVES: To evaluate the effectiveness and safety of Chinese medicinal herbs combined with routine treatments for mumps. SEARCH METHODS: We searched CENTRAL (2015, Issue 1), MEDLINE (1948 to January week 4, 2015), EMBASE (1974 to February 2015), CINAHL (1981 to February 2015), AMED (1985 to April 2014), the Chinese Biomedical Database (CBM) (1980 to February 2015), China National Knowledge Infrastructure (CNKI) (1979 to February 2015), VIP Information (1989 to February 2015), and relevant databases of ongoing trials. SELECTION CRITERIA: Randomised controlled trials (RCTs) of Chinese medicinal herbs for mumps (with or without complications). DATA COLLECTION AND ANALYSIS: Two review authors independently evaluated trial quality and conducted data extraction. We contacted the trial authors for missing data regarding participant allocation. Some trials allocated participants according to the participants' admission sequence, making it a pseudo-random allocation. None of the trials concealed participants' allocation or used blinding. MAIN RESULTS: We did not identify any eligible trials for inclusion. We identified 108 studies that claimed to use random allocation. We excluded 104 studies because the allocation methods the authors had used were not actually randomised. We were unable to contact the trial authors of the remaining four studies. These trials require further evaluation and have been allocated to the 'Studies awaiting classification' section. AUTHORS' CONCLUSIONS: We did not find any RCTs for or against Chinese herbal medicine used in the treatment of mumps. We hope more high-quality RCTs will be conducted in the future.
Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Caxumba/tratamento farmacológico , Fitoterapia/métodos , Medicamentos de Ervas Chinesas/efeitos adversos , Humanos , Fitoterapia/efeitos adversosRESUMO
BACKGROUND: Mumps is an acute, viral illness transmitted by respiratory droplets and saliva. A number of studies published in China have suggested that acupuncture is beneficial for children with mumps but the literature reporting the benefits or harms of acupuncture for mumps has not been systematically reviewed. OBJECTIVES: To determine the efficacy and safety of acupuncture for children with mumps. SEARCH METHODS: We searched CENTRAL (2014, Issue 11), MEDLINE (1950 to November week 3, 2014), EMBASE (1974 to December 2014), CINAHL (1981 to December 2014), AMED (1985 to December 2014), the Chinese BioMedical Literature Database (CBM) (1979 to November 2014), China National Knowledge Infrastructure (CNKI) (1979 to November 2014), Chinese Technology Periodical Database (CTPD) (1989 to November 2014) and Wanfang database (1982 to November 2014). We also handsearched a number of journals (from first issue to current issue). SELECTION CRITERIA: Randomised controlled trials comparing acupuncture with placebo acupuncture, no management, Chinese medication, Western medication or other treatments for mumps. Acupuncture included either traditional acupuncture or contemporary acupuncture, regardless of the source of stimulation (body, electro, scalp, fire, hand, fine needle, moxibustion). DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data. We identified no trials for inclusion in this updated review. MAIN RESULTS: No study met our inclusion criteria. AUTHORS' CONCLUSIONS: We could not reach any conclusion about the efficacy and safety of acupuncture as we identified no trials for inclusion in this review. More high-quality research is needed.
Assuntos
Terapia por Acupuntura/métodos , Caxumba/terapia , Criança , Medicamentos de Ervas Chinesas/uso terapêutico , Febre/terapia , HumanosRESUMO
OBJECTIVE: To systematically evaluate the clinical efficacy and safety of Potassium Dehydroandrographolide Succinate Injection (PDSI) in the treatment of child epidemic parotitis (EP). METHODS: Randomized controlled trials (RCTs) regarding PDSI in the treatment of child EP were searched in China National Knowledge Infrastructure, Wanfang Database, Chinese Biomedical Literature Database, PubMed, and Cochrane Library from inception to July 30, 2013. Two reviewers independently retrieved RCTs and extracted information. The Cochrane risk of bias method was used to assess the quality of included studies, and a meta-analysis was conducted with RevMan 5.2 software. RESULTS: A total of 11 studies with 818 participants were included. The quality of the studies was generally low, among which only one study mentioned the random method. The meta-analysis indicated that PDSI was more effective than the conventional therapy with Western medicine for EP in the outcomes of the total effective rate [relative risk (RR)=1.23, 95% confidence interval (CI) [1.14, 1.33], P<0.01], the time of temperature return to normal, the time of detumescence [mean difference (MD)=-2.10, 95% CI [-2.78,-1.41], P<0.01], and the incidence of complications (RR=0.14, 95% CI [0.03, 0.72], P=0.02). There were 6 adverse drug reactions (ADRs) in this systematic review, 2 of which were mainly represented rash and diarrhea in the experiment group, while another 4 ADRs occurred in the control group. CONCLUSIONS: Based on the systematic review, PDSI was effectiveness and relatively safety in the treatment of child EP. But further rigorously designed trials are warranted to determine its effectiveness.
Assuntos
Diterpenos/administração & dosagem , Caxumba/tratamento farmacológico , Diterpenos/efeitos adversos , Humanos , Ensaios Clínicos Controlados Aleatórios como AssuntoAssuntos
Terapia por Acupuntura , Caxumba/terapia , Terapia por Acupuntura/instrumentação , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Temperatura Alta , Humanos , Masculino , Enxofre/química , Adulto JovemRESUMO
BACKGROUND: Mumps is an acute, viral illness transmitted by respiratory droplets and saliva. A number of studies published in China have suggested that acupuncture is beneficial for children with mumps but the literature reporting the benefits or harms of acupuncture for mumps has not been systematically reviewed. OBJECTIVES: To determine the efficacy and safety of acupuncture for children with mumps. SEARCH METHODS: We searched CENTRAL (2012, Issue 4), MEDLINE (1950 to April week 4, 2012), EMBASE (1974 to May 2012), CINAHL (1981 to May 2012), AMED (1985 to May 2012), the Chinese BioMedicine Database (CBM) (1979 to May 2012), China National Knowledge Infrastructure (CNKI) (1979 to May 2012), Chinese Technology Periodical Database (CTPD) (1989 to May 2012) and WANFANG database (1982 to May 2012). We also handsearched a number of journals (from first issue to current issue). SELECTION CRITERIA: We included randomised controlled trials comparing acupuncture with placebo acupuncture, no management, Chinese medication, Western medication or other treatments for mumps. Acupuncture included either traditional acupuncture or contemporary acupuncture, regardless of the source of stimulation (body, electro, scalp, fire, hand, fine needle, moxibustion). DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data and assessed the quality of included studies. We calculated risk ratios (RR) with their 95% confidence intervals (CI) for the effective percentage and standardised mean differences (SMD) with 95% CIs for the time to cure. MAIN RESULTS: Only one study with 239 participants met our inclusion criteria. There were a total of 120 participants in the acupuncture group, of which 106 recovered, with their temperature returning back to normal and no swelling or pain of the parotid gland; the condition of 14 participants improved, with a drop in temperature and alleviation of swelling or pain of the parotid gland. There were 119 participants in the Western medicine group, of which 56 recovered and the condition of 63 improved. The acupuncture group had a higher recovery rate than the control group. The relative RR of recovery was 1.88 (95% CI 1.53 to 2.30). However, the acupuncture group had a longer time to cure than the control group. The mean was 4.20 days and the standard deviation (SD) was 0.46 in the acupuncture group, while in the control group the mean was 3.78 days and the SD was 0.46.There was a potential risk of bias in the study because of low methodological quality. AUTHORS' CONCLUSIONS: We could not reach any confident conclusions about the efficacy and safety of acupuncture based on one study. More high-quality research is needed.
Assuntos
Terapia por Acupuntura/métodos , Caxumba/terapia , Criança , Medicamentos de Ervas Chinesas/uso terapêutico , Febre/terapia , Humanos , Ensaios Clínicos Controlados Aleatórios como AssuntoRESUMO
BACKGROUND: Mumps is an infectious disease caused by the mumps virus. Chinese physicians generally believe that Chinese medicinal herbs are effective in alleviating symptoms and reducing the duration of mumps. Herbalists tend to develop a treatment plan according to the individual's symptoms. OBJECTIVES: To evaluate the effectiveness and safety of Chinese medicinal herbs for mumps. SEARCH METHODS: We searched CENTRAL Issue 4, 2012, MEDLINE (1948 to April week 3, 2012), EMBASE (1974 to April 2012), CINAHL (1981 to April 2012), AMED (1985 to April 2012), the Chinese Biomedical Database (CBM) (1980 to May 2012), China National Knowledge Infrastructure (CNKI) (1979 to May 2012), VIP Information (1989 to May 2012), and relevant databases of ongoing trials. SELECTION CRITERIA: Randomised controlled trials (RCTs) of Chinese medicinal herbs for mumps (with or without complications). DATA COLLECTION AND ANALYSIS: Two review authors (MS, ZL) independently evaluated trial quality and conducted data extraction. We contacted the trial authors for missing data regarding participant allocation. Some trials allocated participants according to the participants' admitting sequence, making it a pseudo-random allocation. None of the trials concealed participants allocation or used blinding. MAIN RESULTS: We did not identify any eligible trials for inclusion. We identified 102 studies which claimed to use random allocation. Ninety-nine studies were excluded because the allocation methods the authors had used were not actually randomised. We were unable to contact the trial authors of the remaining three studies. These trials require further evaluation and have been allocated to the 'Studies awaiting classification' section. AUTHORS' CONCLUSIONS: We did not find any RCTs for or against Chinese herbal medicine used in the treatment of mumps. We hope more high-quality RCTs will be conducted in the future.
Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Caxumba/tratamento farmacológico , Fitoterapia/métodos , Medicamentos de Ervas Chinesas/efeitos adversos , Humanos , Fitoterapia/efeitos adversosRESUMO
OBJECTIVE: To investigate the in vitro release and transdermal behaviors of mumps cataplasm of complex prescription. METHODS: The improved Franz difficusion was used and the concentration of drugs was detected. DCS was determined by HPLC and flavanoid contents were determined by UV. RESULTS: The accumulation skin permeation percentage of DCS and flavanoid was 32% and 21%, respectively, the in vitro release percentage of DCS and flavanoid was 47% and 42%, respectively. CONCLUSION: The transdermal behavior of mumps cataplasm of complex prescription is an zero-order kinetics progress. The in vitro release behavior is in accordance with the Higuchi equation.
Assuntos
Antivirais/farmacocinética , Diclofenaco/administração & dosagem , Opuntia/química , Extratos Vegetais/administração & dosagem , Pele/metabolismo , Tecnologia Farmacêutica/métodos , Administração Cutânea , Animais , Antivirais/administração & dosagem , Cromatografia Líquida de Alta Pressão , Diclofenaco/análise , Diclofenaco/farmacocinética , Combinação de Medicamentos , Flavonoides/análise , Flavonoides/farmacocinética , Camundongos , Caxumba/tratamento farmacológico , Extratos Vegetais/farmacocinética , Absorção CutâneaAssuntos
Terapia por Acupuntura/história , Adulto , Idoso , Criança , China , Feminino , Herpes Zoster/terapia , História do Século XX , História do Século XXI , Humanos , Masculino , Caxumba/terapia , Paroniquia/terapia , Ciática/terapiaRESUMO
Combined application of mumps and measles vaccine strains in equal doses results in significant decrease of immune response to the former component in humans. It is possible that this phenomenon is related with well-known immunodepressive effect of measles virus, which was demonstrated both in vivo and in vitro. It was previously shown that myelopeptide-2 (MP-2) partially neutralizes suppressive effect of measles vaccine on blast transformation of activated human lymphocytes in vitro. Partial supression of immune response to mumps vaccine by live measles vaccine was reproduced in laboratory animals. It was shown that in experiment MP-2 partially neutralized suppressive effect of measles vaccine.
Assuntos
Adjuvantes Imunológicos/farmacologia , Imunização , Vacina contra Sarampo/administração & dosagem , Sarampo/imunologia , Morbillivirus/imunologia , Vacina contra Caxumba/administração & dosagem , Vacina contra Caxumba/imunologia , Vírus da Caxumba/imunologia , Caxumba/imunologia , Oligopeptídeos/farmacologia , Adjuvantes Imunológicos/administração & dosagem , Animais , Anticorpos Antivirais/sangue , Avaliação Pré-Clínica de Medicamentos , Feminino , Cobaias , Esquemas de Imunização , Terapia de Imunossupressão , Injeções Intramusculares , Sarampo/sangue , Caxumba/sangue , Oligopeptídeos/administração & dosagem , Ratos , Vacinas Combinadas/imunologiaAssuntos
Caxumba/história , Adolescente , Criança , Feminino , História do Século XVII , História do Século XX , História Antiga , História Medieval , Humanos , Inuíte/história , Idioma , Masculino , Caxumba/epidemiologia , Caxumba/prevenção & controle , Vacina contra Caxumba/administração & dosagem , Vírus da Caxumba/imunologiaRESUMO
When dealing with a mumps infection, the complication of meningoencephalitis is quite rare. A 24-year-old soldier with a past MMR vaccination was admitted because of aseptic meningitis. His cognitive functioning was rapidly deteriorating with the swelling of both parotid glands. MR findings revealed discrete lesions in the brainstem and thalamus. He barely recovered within 2 months. Among adults with a failure to get the immunity despite vaccination, institutional crowding can lead to a fatal CNS complication such as mumps meningoencephalitis.
Assuntos
Adulto , Humanos , Adulto Jovem , Tronco Encefálico , Aglomeração , Meningite Asséptica , Meningoencefalite , Militares , Caxumba , Glândula Parótida , Tálamo , VacinaçãoRESUMO
There was a preliminary recognition on mumps during the Qin-Han to Sui-Tang dynasty, laying a foundation for the scholastic development on this topic in later generations. The title of this disease was identified in Song-Jin-Yuan dynasty with gradual deepening on its principle-method-formula-medication system, a great progress of recognition as compared with the previous ages. In the Ming-Qing dynasty, the recognition became even more systematic, with certain breakthrough in the system of principle-method-formula-medication. In modern age, the experiences were inherited and developed to integrate to modern biomedicine, so that the theory and clinical practice become even more perfect.
Assuntos
Medicina Tradicional Chinesa/história , Caxumba/história , História Antiga , História MedievalRESUMO
The immunity to vaccine-preventable diseases included in the Dutch immunisation programme in the general population and among orthodox reformed individuals who refuse vaccination was assessed. The programme induces good protection. However, a large proportion of adults lacks diphtheria and tetanus immunity. Measles, mumps and rubella seroprevalence was somewhat lower among vaccinated compared to unvaccinated cohorts. The prevalence of HibPS antibodies declined during 2.5 years after the fourth vaccination. However, protection occurs also by memory immunity. Herd immunity is sufficient among the general population, but not among orthodox reformed individuals. Immunosurveillance is an efficient way to evaluate the effects of immunisation programmes and identify risk groups for infection.
Assuntos
Doenças Transmissíveis/imunologia , Programas de Imunização/estatística & dados numéricos , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Controle de Doenças Transmissíveis/estatística & dados numéricos , Difteria/imunologia , Difteria/prevenção & controle , Infecções por Haemophilus/imunologia , Infecções por Haemophilus/prevenção & controle , Haemophilus influenzae tipo b/imunologia , Humanos , Lactente , Recém-Nascido , Vacinação em Massa/métodos , Vacinação em Massa/estatística & dados numéricos , Sarampo/imunologia , Sarampo/prevenção & controle , Pessoa de Meia-Idade , Caxumba/imunologia , Caxumba/prevenção & controle , Programas Nacionais de Saúde , Países Baixos/epidemiologia , Poliomielite/imunologia , Poliomielite/prevenção & controle , Avaliação de Programas e Projetos de Saúde , Rubéola (Sarampo Alemão)/imunologia , Rubéola (Sarampo Alemão)/prevenção & controle , Tétano/imunologia , Tétano/prevenção & controleRESUMO
OBJECTIVE: We investigated the assertion that past childhood diseases, acute and febrile infections as well as allergies have a preventive effect on cancer. Former studies on this topic show controversial results and methodical deficits. PATIENTS AND METHODS The investigation was conducted as a retrospective case control study with 111 cancer patients and a group of 109 control persons from 3 hospitals in Berlin. RESULTS: A significant change in the risk of developing cancer could only be observed for mumps (OR = 2.6; increased risk), whooping cough (OR = 2.7; increased risk), and colds in the recent past (OR = 0.7; decreased risk). Fever within the last 5 years showed no association with the development of malign tumors. CONCLUSION: We could not confirm the results of former studies which assumed a preventive effect of childhood diseases and fever on the cancer risk. On the contrary, on the basis of this investigation one might postulate a 2- to 3-fold rise of the cancer risk by mumps or whooping cough. Because of divergent study results, deficits in the study designs, and a low evidence of the present findings no final statement on the association between childhood diseases or fever and cancer should be made.